Prosthetic heart valve is an artificial device surgically implanted for removing damaged heart valves caused by heart valve diseases. Heart valves help in controlling the flow of blood through the heart. Poor functioning of heart valve leads to inadequate blood flow, which requires prosthetic heart valve surgery later. Prosthetic heart valves reduce morbidity and mortality associated with cardiac valve disorder. Cardiac valves disorders can be either congenital or acquired, and sometimes the causes are unknown. There is no cure for heart valve disorder, although proper medication and diet can prevent or delay the occurrence. Transcatheter valve is a recommended minimally invasive surgery which repairs the valve without removing the abnormal heart valve but instead the process involves implanting a replacement valve into an aortic valve place. Alternative treatments for cardiac valve disorder include, suture-less valves, anti-calcification technology and polymer & carbon-based technologies. Valvular stenosis and valvular regurgitation are types of heart valve disorders which are treatable through surgeries. After implanting a prosthetic heart valve, the patient is recommended a blood thinning medication for lifetime to prevent blood clots on the valve. According to the World Health Organization, in 2016, 17.9 million people died from cardiovascular diseases which accounted for 31% of the deaths globally.
Global demand for prosthetic heart valves is driven by increasing number of heart surgeries performed, aging population, and growing base of patients across the world. Prosthetic heart valves is considered a lucrative market globally. Certain other factors, such as, growing health care expenditure and rising awareness regarding proper diagnosis and availability of treatment options for heart valve disorders are also propelling the global market. Furthermore, increasing demand for minimally invasive surgeries, technological advancement, and rising prevalence of cardiac disorders are the major factors expected to generate lucrative opportunities for the global prosthetic heart valves market during the forecast period. Additionally, increasing disposable income in developed countries is boosting the growth of global prosthetic heart valve market. However, reimbursement issues, high cost of development, and expensive treatment, particularly of transcatheter aortic heart valve, are the restraining factors affecting the growth of the prosthetic heart valve market across the globe. Strict government regulations and shortage of skilled professionals further restrict the growth of global prosthetic heart valves market.
Based on product type, the global prosthetic heart valves market can be bifurcated into mechanical heart valves, tissue heart valves, and transcatheter heart valves. Mechanical heart valves can be further classified into mechanical mitral valves and aortic valves. Tissue heart valves can be segmented into stentless tissue valves, stented tissue valves, tissue-engineered valves, and homograft & heterograft valves. Globally, the tissue heart valves is the rapidly growing segment. In terms of end-user, the prosthetics heart valves global market can be divided into hospitals, ambulatory surgical centers, and others. By region, the global prosthetic heart valve market can be segmented into North America, Europe, Asia Pacific, the Middle East, and Latin America. North America dominates the global prosthetic heart valves market, driven by well-developed health care infrastructure, technological advancements, rising health care expenditure, growing number of heart surgeries, and increasing government funding in the region. Prevalence of heart valve disorders in North America is the highest among these regions, followed by that in Europe and Asia Pacific. Asia Pacific is an emerging economy and is expected to grow at the fast pace in during the forecast years. Expected growth of the prosthetic heart valves market in Asia Pacific can be ascribed to improving health care infrastructure and increasing incidence of chronic diseases in the region. Also, growing population and developing economies are the factors propelling the growth of the prosthetic heart valves market in the region during the forecast period.
Major players leading the global prosthetic heart valves market include Edwards Lifesciences Corporation, Medtronic, Abbott Laboratories, Boston Scientific Corporation, Jenavalve Technology, Inc., and Cryolife Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.